PD Dr. Dorota Lubgan

Department of Radiation Oncology

Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial (2019) Wittel UA, Lubgan D, Ghadimi M, Belyaev O, Uhl W, Bechstein WO, Grützmann R, et al. Journal article Single-cycle induction chemotherapy before chemoradiotherapy or surgery in functionally inoperable head and neck squamous cell carcinoma: 10-year results (2019) Breheret M, Lubgan D, Haderlein M, Hecht M, Traxdorf M, Schmidt D, Müller SK, et al. Journal article Time course of pain response and toxicity after whole-nerve-encompassing LINAC-based stereotactic radiosurgery for trigeminal neuralgia—a prospective observational study (2019) Koca S, Distel L, Lubgan D, Weissmann T, Lambrecht U, Lang-Welzenbach M, Eyüpoglu IY, et al. Journal article FOLFIRINOX after Resection of Pancreatic Cancer sets new Standards - Systemic Therapy providing an Impulse for a Local Treatment in resectable Pancreatic Cancer (2019) Semrau S, Lubgan D Journal article, Note Complete Remission with consecutive Pneumonitis in metastatic Bronchogenic Carcinoma after combination of Radiotherapy and Nivolumab - Immunological Correlate in peripheral Blood (2019) Hecht M, Donaubauer AJ, Becker I, Rutzner S, Lubgan D, Lettmaier S, Haderlein M, et al. Conference contribution Long-term control with chemoradiation of initially metastatic mixed adenoneuroendocrine carcinoma of the rectum: A case report (2019) Semrau S, Agaimy A, Pavel ME, Lubgan D, Schmidt D, Golcher H, Grützmann R, et al. Journal article Noncurated Data Lead to Misinterpretation of Treatment Outcomes in Patients With Prostate Cancer After Salvage or Palliative Radiotherapy (2019) Rutzner S, Ganslandt OT, Fietkau R, Prokosch HU, Lubgan D Journal article Reliability of determining the resectability of locally progressed pancreatic ductal adenocarcinomas - results from the CONKO-007 multicenter randomized controlled trial (EudraCT:2009-014476-21) (2018) Wittel UA, Golcher H, Gruetzmann R, Bechstein WO, Belyaev O, Uhl W, Ghadimi M, et al. Conference contribution 12x6Gy-the Erlangen stereotactic radiotherapy treatment concept result in 95% local progression-free survival for bronchial carcinoma and 83% for pulmonary metastases after 3 years (2018) Lubgan D, Rutzner S, Lambrecht U, Fietkau R Conference contribution Salvage external beam radiation therapy of biochemical relapse after radical prostatectomy: Results and potential role of PET/CT (2018) Rutzner S, Lubgan D, Wullich B, Kuehn R, Kuwert T, Fietkau R Conference contribution